IL6 and immunoglobulin G4-related sclerosing disease: Although we could not confirm the association between serum IL-6 concentrations and specific clinical manifestations, probably due to a relatively small number of patients in this study, further studies are required to sub-classify the MCD-like subtype within type 1 AIP/IgG4-RD patients based on the evaluation of serum IL-6 levels.